what is glp-1 drugs Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Understanding GLP-1 Drugs: Cost, Safety,
Description
Phase-3 trials suggest the oral form delivers up to ~17% average weight loss, compared to up to ~20% for injectables
YK: Writing original draft, Writing review & editing, Data curation
Whatever time you choose, the critical requirement is an empty stomach
Fulcher G, Matthews D, Perkovic V, De Zeeuw D, Mahaffey K, Mathieu C, et al
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
(2022) suggests that GLP-1 RAs may be associated with a reduced risk of atrial arrhythmias
